P21675 (TAF1_HUMAN) Homo sapiens (Human)

Transcription initiation factor TFIID subunit 1 UniProtKBInterProSTRINGInteractive Modelling

1872 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12)

Available Structures

38 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Human TFIID canonical state Heteromer
O00268; P20226; P49848; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
36-1083
Assess
TFIID lobe C subcomplex Heteromer
P49848; Q15545; Q6P1X5; Q7Z7C8;
333-1242
Assess
SCP promoter-bound TFIID-TFIIA in post TBP-loading state Heteromer
O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
341-1242
Assess
SCP promoter-bound TFIID-TFIIA in initial TBP-loading state Heteromer
O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
341-1242
Assess
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P20226; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;341-1205
Assess
TFIID-based intermediate PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;341-1205
Assess
p53-bound TFIID-based core PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P20226; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;341-1205
Assess
TFIID-based intermediate PIC on PUMA promoter Heteromer
A0A480TA59; A0A481BYI6; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; O00268; P13984; P20226; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;341-1205
Assess
TFIID-based core PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;341-1205
Assess
TFIID-based core PIC on PUMA promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;341-1205
Assess
TFIID in canonical conformation Heteromer
O00268; P20226; P49848; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
341-1205
Assess
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P20226; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;341-1205
Assess
TFIID in rearranged conformation Heteromer
O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
341-1205
Assess
Crystal Structure of a TAF1-TAF7 Complex in Human Transcription Factor IID Heteromer
Q15545;
GOL;588-1088
Assess
Structure of human TFIID-IIA bound to core promoter DNA Heteromer
P20226; P49848; P52655; P52657; Q15545; Q6P1X5; Q7Z7C8;
588-1088
Assess
Human TFIID bound to promoter DNA and TFIIA Heteromer
O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15545; Q16514; Q16594; Q6P1X5; Q7Z7C8;
588-1083
Assess
Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modification… Heteromer
Q9Y294;
SO4;1353-1628
Assess
Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide Heteromer
P62805;
CA;1500-1632
Assess
Crystal structure of TAF1 BD2 Bromodomain bound to a crotonyllysine peptide Heteromer
P62805;
1501-1630
Assess
Human TFIID Lobe A canonical Heteromer
O00268; P20226; P49848; Q12962; Q15542; Q15543; Q15544; Q16514; Q16594; Q5VWG9;
36-119
Assess
CRYSTAL STRUCTURE OF THE DOUBLE BROMODOMAIN MODULE FROM HUMAN TAFII250monomerSO4;1359-1625
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to GNE-371monomerG9V;EDO;1379-1634
Assess
Crystal Structure of the tandem bromodomains of human Transcription initiation factor TFIID subunit…monomerTRS;1377-1631
Assess
Crystal structure of the unliganded tandem bromodomain (BD1, BD2) of human TAF1monomerEDO;1378-1630
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-585monomer18×EDO;PEG;XWV;1380-1628
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-295monomerXXV;EDO;1379-1626
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-589monomerEDO;HEZ;XWY;1379-1625
Assess
Crystal structure of the tandem bromodomain of human TAF1 (TAF1-T) bound to ZS1-681monomerEDO;06M;DMS;1380-1626
Assess
Bivalent Inhibitor UNC4512 Bound to the TAF1 Bromodomain TandemmonomerDKH;1377-1621
Assess
TAF1(2) bound to a pyrrolopyridone compoundmonomer67B;CA;1500-1638
Assess
Second bromodomain of TAF1 bound to a pyrrolopyridone compoundmonomer67C;1501-1635
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase inhibitor AZ20monomerVCD;EDO;GOL;1501-1635
Assess
Crystal structure of the second bromodomain of human TAF1 in complex with BAY-299 chemical probemonomerEDO;7M8;1501-1635
Assess
TAF1-BD2 bromodomain in complex with (E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]py…monomer69G;1501-1629
Assess
Crystal Structure Analysis of TAF1 BromodomainmonomerNQY;1500-1627
Assess
Crystal Structure Analysis of TAF1 BromodomainmonomerNQV;1501-1627
Assess
Crystal Structure Analysis of TAF1 BromodomainmonomerNQP;1501-1627
Assess
Crystal Structure of the second bromodomain of human Transcription initiation factor TFIID subunit …monomerEDO;GOL;1501-1623
Assess

3 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.617egd.1.A341-1242
100.00
Assess
monomer0.557egc.1.K341-1205
100.00
Assess
monomer0.557ege.1.A341-1205
100.00
Assess

55 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.696dne.1.A1402-1508
25.11
Assess
Isoform 2monomer0.665i8b.1.A1534-1631
29.59
Assess
Isoform 2monomer0.617egd.1.A362-1263
100.00
Assess
Isoform 2monomer0.557egc.1.K362-1226
100.00
Assess
Isoform 2monomer0.557ege.1.A362-1226
100.00
Assess
Isoform 2monomer0.506mzl.1.A36-1104
100.00
Assess
Isoform 3monomer0.696dne.1.A1381-1487
25.11
Assess
Isoform 3monomer0.645u7g.1.A1513-1610
29.59
Assess
Isoform 3monomer0.617egd.1.A341-1242
99.50
Assess
Isoform 3monomer0.557egc.1.K341-1205
99.50
Assess
Isoform 3monomer0.557ege.1.A341-1205
99.50
Assess
Isoform 4monomer0.696dne.1.A1381-1487
25.11
Assess
Isoform 4monomer0.675w55.1.A1509-1607
29.59
Assess
Isoform 4monomer0.607egd.1.A341-1242
99.52
Assess
Isoform 4monomer0.557egc.1.K341-1205
99.52
Assess
Isoform 4monomer0.547ege.1.A341-1205
99.52
Assess
Isoform 5monomer0.696dne.1.A1381-1487
25.11
Assess
Isoform 5monomer0.675w55.1.A1509-1607
29.59
Assess
Isoform 5monomer0.617egd.1.A341-1242
99.44
Assess
Isoform 5monomer0.557egc.1.K341-1205
99.44
Assess
Isoform 5monomer0.557ege.1.A341-1205
99.44
Assess
Isoform 6monomer0.696dne.1.A1381-1487
25.11
Assess
Isoform 6monomer0.645u7g.1.A1513-1610
29.59
Assess
Isoform 6monomer0.617egd.1.A341-1242
99.89
Assess
Isoform 6monomer0.557egc.1.K341-1205
99.89
Assess
Isoform 6monomer0.557ege.1.A341-1205
99.89
Assess
Isoform 7monomer0.696dne.1.A1381-1487
25.11
Assess
Isoform 7monomer0.645u7g.1.A1513-1610
29.59
Assess
Isoform 7monomer0.617egd.1.A341-1242
99.89
Assess
Isoform 7monomer0.557egc.1.K341-1205
99.89
Assess
Isoform 7monomer0.557ege.1.A341-1205
99.89
Assess
Isoform 8monomer0.686dne.1.A1381-1487
25.96
Assess
Isoform 8monomer0.617egd.1.A341-1242
99.56
Assess
Isoform 8monomer0.606dne.1.A1508-1590
30.49
Assess
Isoform 8monomer0.557egc.1.K341-1205
99.56
Assess
Isoform 8monomer0.557ege.1.A341-1205
99.56
Assess
Isoform 9monomer0.686dne.1.A1381-1487
25.11
Assess
Isoform 9monomer0.665i8b.1.A1513-1610
29.59
Assess
Isoform 9monomer0.627egd.1.A341-1242
99.44
Assess
Isoform 9monomer0.557egc.1.K341-1205
99.44
Assess
Isoform 9monomer0.557ege.1.A341-1205
99.44
Assess
Isoform 10monomer0.644n3w.1.A1382-1488
19.63
Assess
Isoform 10monomer0.617egd.1.A341-1242
99.93
Assess
Isoform 10monomer0.567egc.1.K341-1205
99.93
Assess
Isoform 10monomer0.557ege.1.A341-1205
99.93
Assess
Isoform 11monomer0.644n3w.1.A1382-1488
19.63
Assess
Isoform 11monomer0.617egd.1.A341-1242
99.67
Assess
Isoform 11monomer0.557egc.1.K341-1205
99.67
Assess
Isoform 11monomer0.557ege.1.A341-1205
99.67
Assess
Isoform 12monomer0.696dne.1.A1402-1508
25.11
Assess
Isoform 12monomer0.645u7g.1.A1534-1631
29.59
Assess
Isoform 12monomer0.617egd.1.A362-1263
100.00
Assess
Isoform 12monomer0.557egc.1.K362-1226
100.00
Assess
Isoform 12monomer0.557ege.1.A362-1226
100.00
Assess
Isoform 12monomer0.506mzl.1.A36-1104
100.00
Assess

Alignments